TABLE 1.

Recipient pretransplant characteristics

Characteristic	1	2	3	4	5	6	7	8	9
Age, years	41	51	54	54	34	25	63	51	24
Sex	Male	Male	Female	Male	Male	Female	Male	Female	Male
Cause of end-stage heart failure	Idiopathic CM	Post-cardiotomy	Post-cardiotomy	Idiopathic CM	Viral CM	Massive myocardial infarction (septal, anterior and lateral)	Ischemic CM	Post-cardiotomy	Congenital heart disease
Mechanical support before transplant	None	TAH	Thoratec* LVAD	None	TAH	TAH	Novacor† LVAS	Symbion‡ LVAD + BioMedicus§ RVAD	IABP followed by TAH
Preoperative creatinine level, mmol/L	109	154	99	166	133	69 before first transplant, 49 before second transplant	73	181	115 before first transplant, 359 before second transplant
Preoperative pulmonary arterial pressure, mmHg	55/33 on milrinone	Not available because patient was on TAH before transplant	35/20	52/25	23/18	Not available because patient was on TAH before both transplants	63/32	70/32	66/36 before first transplant, 30/20 before second transplant

^*Thoratec Laboratories Corporation, USA;

^†WorldHeart Inc, USA;

^‡Symbion Corporation, USA;

^§Medtronic BioMedicus, USA. CM Cardiomyopathy; IABP Intra-aortic balloon pump; LVAD Left ventricular assist device; LVAS Left ventricular assist system; RVAD Right ventricular assist device; TAH Total artificial heart